Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taizhou Qirui Pharmaceutical Technology is a China-based company specializing in the research, development, and production of pharmaceutical intermediates and fine chemicals. Located in the Taizhou pharmaceutical industrial cluster, the company provides custom synthesis and contract manufacturing services to global pharmaceutical and biotechnology firms. Their expertise lies in complex chemical synthesis and the production of high-quality building blocks essential for the development of Active Pharmaceutical Ingredients (APIs). Taizhou Qirui supports drug discovery and development through its dedicated chemical R&D capabilities and pilot-scale production facilities. The company is recognized for its focus on process optimization and the delivery of specialized chemical precursors for small molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taizhou Qirui Pharmaceutical Technology.